Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on February 23, 2010. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Multifunctional Resuscitation Fluid (MRF)

Closed
ONRBAA10-008Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

NAICS

541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Russelle DunsonContract Specialist
Michael I GivenProgram Officer

Full Description

Show more
The Force Health Protection Program of the Warfighter Performance Department at the Office of Naval Research (Code 342) is soliciting white papers and full proposals for Multifunctional Resuscitation Fluid. White Papers are desired for all offerors seeking FY 2011 initial funding. The objective of this effort is to obtain FDA Investigational New Drug (IND) approval and completion of a Phase I clinical trial for a multifunctional resuscitation fluid (MRF) product. The MRF will replace lost blood volume, provide oxygen to tissues, and replace coagulation factors lost during bleeding to prevent further blood loss. The product will not require refrigeration. The product will have a long shelf-life, be easily reconstituted (if dried) and administered, restore intravascular volume, provide oxygen to tissues, and restore coagulation factors lost due to hemorrhage. It is anticipated that award will be in the form of cost-type contract, specifically Indefinite Delivery Indefinite Quantity (IDIQ) contracts with cost-type Task Orders made off of those IDIQs.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS